首页> 美国卫生研究院文献>British Journal of Cancer >Phase I study of nab-paclitaxel gemcitabine and bevacizumab in patients with advanced cancers

【2h】

Phase I study of nab-paclitaxel gemcitabine and bevacizumab in patients with advanced cancers

机译：晚期癌症患者中nab-紫杉醇吉西他滨和贝伐单抗的I期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background We performed a phase I modified 3 + 3 dose escalation study to evaluate the safety and activity of bevacizumab plus gemcitabine and nab-paclitaxel in patients with advanced solid tumours.

机译：背景我们进行了I期3×+ 3剂量递增研究，以评估贝伐单抗联合吉西他滨和纳布-紫杉醇在晚期实体瘤患者中的安全性和活性。

著录项

期刊名称 British Journal of Cancer
作者
Shiraj Sen; Shumei Kato; Rishi Agarwal; Sarina Piha-Paul; Kenneth Hess; Daniel Karp; Filip Janku; Siqing Fu; Aung Naing; Shubham Pant; Gerald Falchook; Chad Tang; Xifeng Wu; Yuanqing Ye; Apostolia Tsimberidou; Vivek Subbiah; Razelle Kurzrock; Lauren Byers; Shannon Westin; JoAnn Lim; Stacie Bean; Allison Bass; Ly Nguyen; Funda Meric-Bernstam; David Hong;
展开▼
作者单位

展开▼
年(卷),期 2018(118),11
年度 2018
页码 1419–1424
总页数 6
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases. [J] . Apostolia M Tsimberidou, Yang Ye, Jennifer Wheler, Cancer chemotherapy and pharmacology. . 2013,第4期

机译：I期研究针对晚期癌症和主要肝转移患者的nab-紫杉醇联合静脉注射吉西他滨和贝伐单抗的肝动脉输注。
2. A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases. [J] . Apostolia M Tsimberidou, Yang Ye, Jennifer Wheler, Cancer chemotherapy and pharmacology. . 2013,第4期

机译：肝癌肝动脉输注与静脉胚轴和贝伐单抗的肝动脉输注治疗晚期癌症和主要肝转移患者的肝动脉输注。
3. A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study [J] . Cohen Steven J., ONeil Bert H., Berlin Jordan, Cancer chemotherapy and pharmacology. . 2016,第4期

机译：厄洛替尼联合吉西他滨和纳布紫杉醇在先前未经治疗的晚期胰腺癌患者中的1b阶段研究：学术肿瘤胃肠道癌症联合研究
4. Bioelectrical impedance phase angle as a predictor of survival in patients with advanced cancer. [C] . M. Marra, L. Santarpia, C. Montagnese, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：生物电阻抗相角可作为晚期癌症患者生存的预测指标。
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. A Phase I Study of Hepatic Arterial Infusion of Nab-Paclitaxel inCombination with Intravenous Gemcitabine and Bevacizumab for Patients withAdvanced Cancers and Predominant Liver Metastases [O] . Apostolia M. Tsimberidou, Yang Ye, Jennifer Wheler, -1

机译：肝动脉输注NAB-PACLITAXEL的阶段研究与静脉内吉西他滨和Bevacizumab的组合先进的癌症和主要肝转移
7. A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases [O] . Apostolia M. Tsimberidou, Yang Ye, Jennifer Wheler, 2013

机译：肝动脉输注Nab-紫杉醇与静脉胚轴和贝伐单抗的肝动脉输注研究患者晚期癌症和主要肝转移患者

Phase I study of nab-paclitaxel gemcitabine and bevacizumab in patients with advanced cancers

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅